«Immune Complex Diseases

Below is an extended Immune Complex Diseases patents listing. Click here to return to the Immune Complex Diseases main in depth entry.

Patents :
US Patent No.	Title
7094567	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7163797	50 human secreted proteins
7169906	PRO211 polypeptides
7175988	Human G-protein Chemokine Receptor (CCR5) HDGNR10
7179605	Fibronectin precursor biopolymer markers indicative of alzheimer's disease
7179606	IG heavy chain, IG kappa, IG lambda biopolymer markers predictive of Alzheimer's disease
7179610	Complement C3 precursor biopolymer markers indicative of insulin resistance
7189690	Albumin fusion proteins
7196164	Secreted protein HHTLF25
7208308	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7208312	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7151160	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7148014	Methods of inhibiting phagocytosis
7147853	Anti-pro211 polypeptide antibodies
7097989	Complement C3 precursor biopolymer markers predictive of type II diabetes
7098240	Compounds
7112327	Inhibition of complement activation
7122327	Biopolymer markers indicative of type II diabetes
7125678	Protein biopolymer markers predictive of type II diabetes
7125726	Method and kit for diagnosing myocardial infarction
7125896	Thiophene carboxamide compounds as inhibitors of enzyme IKK-2
7132244	Betaine/GABA transport protein biopolymer marker indicative of insulin resistance
7135297	Protein biopolymer markers indicative of insulin resistance
7141547	Albumin fusion proteins comprising GLP-1 polypeptides
7223586	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7229638	Biopolymer marker indicative of disease state having a molecular weight of 1525 Daltons
7355002	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7358334	B cell-targeted toxins for humoral immune response reduction and methods of use thereof
7358376	Substituted Thiophene compounds
7368527	HADDE71 polypeptides
7368531	Human secreted proteins
7375192	Antibodies that specifically bind to chemokine beta-4
7378507	PRO217 polypeptides
7381800	Antibodies to HBIMF63 polypeptide
7393934	Human G-protein chemokine receptor (CCR5) HDGNR10
7396659	Inhibitors of nitric oxide synthase to treat type 1 diabetes
7332631	Fc receptor modulating compounds and compositions
7332168	Composition for the elimination of autoreactive B-cells
7329501	Interalpha trypsin inhibitor biopolymer markers indicative of insulin resistance
7238660	Albumin fusion proteins
7238667	Albumin fusion proteins
7241865	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7271198	Method of treating autoimmune diseases
7282206	Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
7294688	Biopolymer marker indicative of disease state having a molecular weight of 1348 daltons
7307152	Secreted and transmembrane polypeptides and nucleic acids encoding the same
7314717	Biopolymer marker indicative of disease state having a molecular weight of 1562 daltons
7314762	Apolipoprotein biopolymer markers indicative of insulin resistance
7323440	De-immunized MOG (poly)peptide constructs
7411051	Antibodies to HDPPA04 polypeptide

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright 1997-2008 - BioPortfolio Limited.